CMRE
Costamare Inc.
CMRE has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over CMRE overall, supported by stronger fundamentals and stronger modeled upside.
CMRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Weak | |
| Stable |
CMRE's profitability is currently strong, and its balance sheet is stable, but its revenue and cash flow are under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CMRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.6x | $6.65 | -50% |
| Fair | 4.9x | $12.61 | -4.8% |
| Current | 5.1x | $13.24 | — |
| Forward | 5.4x | $13.24 | — |
| Expensive | 6.5x | $16.77 | +27% |
Historical ranges are pointers, not guarantees.
CMRE's PE is in its fair range at 5.1x. On analysts' estimates for next year's earnings, today's price would be 5.4x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CMRE Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect CMRE's revenue to grow, but its profitability to weaken.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over CMRE on the outlook, with more favorable earnings and profitability expectations.
CMRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.45 | -5.4% |
| Q3 2026 | $2.59 | +3.6% |
| Q2 2026 | $2.63 | +11% |
| Q1 2026 | $2.68 | +9.8% |
| Q4 2025 | $2.85 | +17% |
| Q3 2025 | $2.50 | -17% |
| Q2 2025 | $2.36 | -16% |
| Q1 2025 | $2.44 | -5.1% |
| Q4 2024 | $2.44 | -17% |
CMRE has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CMRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212.1M | -5.8% |
| Q2 2026 | $200.8M | -4.8% |
| Q1 2026 | $201.6M | -55% |
| Q4 2025 | $212M | -61% |
| Q3 2025 | $225.2M | -59% |
| Q2 2025 | $210.9M | -3.2% |
| Q1 2025 | $446.2M | -6.1% |
| Q4 2024 | $548.4M | +11% |
CMRE's revenue has slid since its 2024 peak: $212M last quarter, down 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | -9 points |
| Q2 2026 | 45% | -5 points |
| Q1 2026 | 44% | +20 points |
| Q4 2025 | 48% | +24 points |
| Q3 2025 | 52% | +33 points |
| Q2 2025 | 50% | -4.3 points |
| Q1 2025 | 24% | +2.4 points |
| Q4 2024 | 23% | +1.7 points |
CMRE has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CMRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CMRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$255.9M | -187% |
| Q1 2026 | $25.5M | -81% |
| Q4 2025 | $66.2M | +174% |
| Q3 2025 | $30.9M | -52% |
| Q2 2025 | $295M | +$295.5M |
| Q1 2025 | $137.3M | +47% |
| Q4 2024 | $24.1M | +$90.5M |
| Q3 2024 | $64.9M | +$144.3M |
CMRE has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CMRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.7K shares |
| 1 year | +0.4% | +468K shares |
| 3 years | -0.6% | -699K shares |
| 5 years | -2.1% | -2.6M shares |
| Available history | +1.7% | +2M shares |
CMRE has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CMRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.8x | Moderate |
CMRE's net debt is about 2.2 years of its operating earnings (EBITDA), up from 1.9 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 16.2 | Oversold |
CMRE's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CMRE PE vs Industrials Sector
| Metric | CMRE | Sector median | Relative |
|---|---|---|---|
| PE | 5.1x | 24x | 79% below |
| PE % | 54 | 58 | 4 pts below |
CMRE is trading at 5.1x earnings, a 79% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CMRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.2 | 6.4% below |
| 20 week MA | $14.8 | 10% below |
| 50 week MA | $15.7 | 16% below |
| 100 week MA | $13.3 | 0.4% below |
| 200 week MA | $12.4 | 6.9% above |
CMRE has fallen below most of its moving averages, though it's still 6.9% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CMRE on trend strength, trading above more of its moving averages.
CMRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.59 | $7.84 | -18% |
| 2021 | $7.84 | $12.2 | +56% |
| 2022 | $12.2 | $9.06 | -26% |
| 2023 | $9.06 | $10.4 | +15% |
| 2024 | $10.4 | $12.8 | +23% |
| 2025 | $12.8 | $15.7 | +23% |
| 2026 YTD | $15.7 | $13.2 | -16% |
CMRE has finished higher in four of the last six years. It's down 16% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CMRE on returns for 2026, with the stronger performance.